Meetings & Events

MYCAPSSA® (octreotide) Delayed-Release Oral Capsules: A New Option for Appropriate Patients with Acromegaly

August 27, 2020

Product Theater Details: 3:45–4:45 PM EDT on Thursday, September 10, 2020

Presenter: Anthony Heaney, MD, PhD
University of California Los Angeles

Dr. Anthony Heaney will discuss MYCAPSSA® (octreotide) Delayed-Release Oral Capsules: A New Option for Appropriate Patients with Acromegaly. During this presentation, Dr. Heaney will talk about Transient Permeability Enhancer (TPE) technology, MYCAPSSA Phase 3 Clinical Trails and Safety Profile, as well as Dosing and Patient Services.

This program is sponsored by and the speaker is presenting on behalf of Chiasma, Inc. It is being presented consistent with FDA guidelines and is not approved for continuing education credit.

Last Updated:
Back to top

Who We Are

For 100 years, the Endocrine Society has been at the forefront of hormone science and public health. Read about our history and how we continue to serve the endocrine community.